Global Direct-To-Consumer Disease Risk And Health Test Market Size, Status And Forecast 2019-2025


Report ID : RNR-264586 Category : Pharma Healthcare Published Date : Mar-2019
Publisher : Research-N-Reports Pages : 123 Format : PDF

Avail 15% Discount, Use RNR15 Coupon Code.
T&C*

The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.
In 2018, the global Direct-to-consumer Disease Risk and Health Test market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Direct-to-consumer Disease Risk and Health Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Direct-to-consumer Disease Risk and Health Test development in United States, Europe and China.

The key players covered in this study
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes

Market segment by Type, the product can be split into
Celiac Disease
Parkinson Disease
Alzheimer Disease
Other

Market segment by Application, split into
Online
Offline

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Direct-to-consumer Disease Risk and Health Test status, future forecast, growth opportunity, key market and key players.
To present the Direct-to-consumer Disease Risk and Health Test development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Direct-to-consumer Disease Risk and Health Test are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Type (2014-2025)
1.4.2 Celiac Disease
1.4.3 Parkinson Disease
1.4.4 Alzheimer Disease
1.4.5 Other
1.5 Market by Application
1.5.1 Global Direct-to-consumer Disease Risk and Health Test Market Share by Application (2014-2025)
1.5.2 Online
1.5.3 Offline
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Direct-to-consumer Disease Risk and Health Test Market Size
2.2 Direct-to-consumer Disease Risk and Health Test Growth Trends by Regions
2.2.1 Direct-to-consumer Disease Risk and Health Test Market Size by Regions (2014-2025)
2.2.2 Direct-to-consumer Disease Risk and Health Test Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Direct-to-consumer Disease Risk and Health Test Market Size by Manufacturers
3.1.1 Global Direct-to-consumer Disease Risk and Health Test Revenue by Manufacturers (2014-2019)
3.1.2 Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio (CR5 and HHI)
3.2 Direct-to-consumer Disease Risk and Health Test Key Players Head office and Area Served
3.3 Key Players Direct-to-consumer Disease Risk and Health Test Product/Solution/Service
3.4 Date of Enter into Direct-to-consumer Disease Risk and Health Test Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Direct-to-consumer Disease Risk and Health Test Market Size by Type (2014-2019)
4.2 Global Direct-to-consumer Disease Risk and Health Test Market Size by Application (2014-2019)

5 United States
5.1 United States Direct-to-consumer Disease Risk and Health Test Market Size (2014-2019)
5.2 Direct-to-consumer Disease Risk and Health Test Key Players in United States
5.3 United States Direct-to-consumer Disease Risk and Health Test Market Size by Type
5.4 United States Direct-to-consumer Disease Risk and Health Test Market Size by Application

6 Europe
6.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size (2014-2019)
6.2 Direct-to-consumer Disease Risk and Health Test Key Players in Europe
6.3 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type
6.4 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application

7 China
7.1 China Direct-to-consumer Disease Risk and Health Test Market Size (2014-2019)
7.2 Direct-to-consumer Disease Risk and Health Test Key Players in China
7.3 China Direct-to-consumer Disease Risk and Health Test Market Size by Type
7.4 China Direct-to-consumer Disease Risk and Health Test Market Size by Application

8 Japan
8.1 Japan Direct-to-consumer Disease Risk and Health Test Market Size (2014-2019)
8.2 Direct-to-consumer Disease Risk and Health Test Key Players in Japan
8.3 Japan Direct-to-consumer Disease Risk and Health Test Market Size by Type
8.4 Japan Direct-to-consumer Disease Risk and Health Test Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size (2014-2019)
9.2 Direct-to-consumer Disease Risk and Health Test Key Players in Southeast Asia
9.3 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size by Type
9.4 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size by Application

10 India
10.1 India Direct-to-consumer Disease Risk and Health Test Market Size (2014-2019)
10.2 Direct-to-consumer Disease Risk and Health Test Key Players in India
10.3 India Direct-to-consumer Disease Risk and Health Test Market Size by Type
10.4 India Direct-to-consumer Disease Risk and Health Test Market Size by Application

11 Central & South America
11.1 Central & South America Direct-to-consumer Disease Risk and Health Test Market Size (2014-2019)
11.2 Direct-to-consumer Disease Risk and Health Test Key Players in Central & South America
11.3 Central & South America Direct-to-consumer Disease Risk and Health Test Market Size by Type
11.4 Central & South America Direct-to-consumer Disease Risk and Health Test Market Size by Application

12 International Players Profiles
12.1 23andMe
12.1.1 23andMe Company Details
12.1.2 Company Description and Business Overview
12.1.3 Direct-to-consumer Disease Risk and Health Test Introduction
12.1.4 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2014-2019)
12.1.5 23andMe Recent Development
12.2 MyHeritage
12.2.1 MyHeritage Company Details
12.2.2 Company Description and Business Overview
12.2.3 Direct-to-consumer Disease Risk and Health Test Introduction
12.2.4 MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2014-2019)
12.2.5 MyHeritage Recent Development
12.3 LabCorp
12.3.1 LabCorp Company Details
12.3.2 Company Description and Business Overview
12.3.3 Direct-to-consumer Disease Risk and Health Test Introduction
12.3.4 LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2014-2019)
12.3.5 LabCorp Recent Development
12.4 Myriad Genetics
12.4.1 Myriad Genetics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Direct-to-consumer Disease Risk and Health Test Introduction
12.4.4 Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2014-2019)
12.4.5 Myriad Genetics Recent Development
12.5 Ancestry.com
12.5.1 Ancestry.com Company Details
12.5.2 Company Description and Business Overview
12.5.3 Direct-to-consumer Disease Risk and Health Test Introduction
12.5.4 Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2014-2019)
12.5.5 Ancestry.com Recent Development
12.6 Quest Diagnostics
12.6.1 Quest Diagnostics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Direct-to-consumer Disease Risk and Health Test Introduction
12.6.4 Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2014-2019)
12.6.5 Quest Diagnostics Recent Development
12.7 Gene By Gene
12.7.1 Gene By Gene Company Details
12.7.2 Company Description and Business Overview
12.7.3 Direct-to-consumer Disease Risk and Health Test Introduction
12.7.4 Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2014-2019)
12.7.5 Gene By Gene Recent Development
12.8 DNA Diagnostics Center
12.8.1 DNA Diagnostics Center Company Details
12.8.2 Company Description and Business Overview
12.8.3 Direct-to-consumer Disease Risk and Health Test Introduction
12.8.4 DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2014-2019)
12.8.5 DNA Diagnostics Center Recent Development
12.9 Invitae
12.9.1 Invitae Company Details
12.9.2 Company Description and Business Overview
12.9.3 Direct-to-consumer Disease Risk and Health Test Introduction
12.9.4 Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2014-2019)
12.9.5 Invitae Recent Development
12.10 IntelliGenetics
12.10.1 IntelliGenetics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Direct-to-consumer Disease Risk and Health Test Introduction
12.10.4 IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2014-2019)
12.10.5 IntelliGenetics Recent Development
12.11 Ambry Genetics
12.12 Living DNA
12.13 EasyDNA
12.14 Pathway Genomics
12.15 Centrillion Technology
12.16 Xcode
12.17 Color Genomics
12.18 Anglia DNA Services
12.19 African Ancestry
12.20 Canadian DNA Services
12.21 DNA Family Check
12.22 Alpha Biolaboratories
12.23 Test Me DNA
12.24 23 Mofang
12.25 Genetic Health
12.26 DNA Services of America
12.27 Shuwen Health Sciences
12.28 Mapmygenome
12.29 Full Genomes

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details